AXIOS November 21, 2023
Adriel Bettelheim

The Food and Drug Administration has finalized a long-running effort to require prescription drug ads on TV and radio to clearly lay out potential side effects and when a person should avoid a medicine.

Why it matters: While the number of drug ads has surged and they account for billions of dollars in direct-to-consumer marketing, experts say they primarily rely on emotional appeals and focus on a drug’s benefits over potential risks.

  • DTC drug ads, which are banned in all other developed countries besides New Zealand, can influence whether consumers seek out more information about a drug, visit a health care provider to discuss an advertised product, or skip a doctor’s visit.

Driving the news: The FDA on...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, FDA, Govt Agencies, Pharma, Pharma / Biotech
At Current Prices GLP-1s Aren’t Cost-Effective, Limiting Access To Patients
Latigo raises $150M to get non-opioid pain drugs through key tests
AstraZeneca Aims to Make Cell Therapy More Accessible With $425M EsoBiotec Acquisition
CMS doubles down on Medicare drug price negotiations
Drug shortages could surge 25% as AI reshapes specialty pharmacy: Survey

Share This Article